Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

National Aggregate

Five-Year Summary: July 2009 to June 2014

Tables and graphs report on cancer screening services provided through the program in a recent 5-year period. The data represent clinical services funded directly through the NBCCEDP as reported in the April 2015 submission of the NBCCEDP Minimum Data Elements (MDE).

National aggregate data are typically used to report results from the program and as a standard to compare results of grantee programs. Comparing data across grantee programs is not advised due to extensive variation across programs. For information on interpreting the data, refer to Screening Program Data. For information on the program, refer to About the Program.

Screening Totals by Year

Number of Women Screened by Program Year
Total women screened in each program year: 2010: 558,244; 2011: 548,645; 2012: 543,263; 2013: 534,365; and 2014: 451,209. Women who received NBCCEDP-funded Pap tests: 2010: 302,778; 2011: 284,549; 2012: 273,413; 2013: 231,802; and 2014: 179,533. Women who received NBCCEDP-funded mammograms: 2010: 325,292; 2011: 335,044; 2012: 341,174; 2013: 348,550; and 2014: 298,726.

This bar graph illustrates the number of women who received NBCCEDP-funded screenings by program year from July 2009 to June 2014.

Program year (PY) is defined as July 1 through June 30. For example, “PY10” represents July 1, 2009 through June 30, 2010.

Program Overview

Women Served through the NBCCEDP
Category Number
Women served [1] 1,770,129
Women screened [2] 1,694,573
Women receiving Pap tests 1,032,136
Women receiving mammography 1,085,325

Each category reports counts of unduplicated women receiving services within the 5-year period. Women may be counted in more than one category.

1: Women served includes women receiving any NBCCEDP-funded screen or diagnostic procedure.

2: Women screened includes women receiving any NBCCEDP-funded screen (mammography, clinical breast exam, or Pap test).

Data source: April 2015 submission of NBCCEDP Minimum Data Elements (MDE).

Cervical Cancer Screening

Distribution of Women Receiving Pap Tests by Race/Ethnicity

White: 44.3%, Black: 14.2%, Asian/Pacific Islander: 6.7%, American Indian/Alaska Native: 4.7%, Multiracial: 0.7%, Hispanic: 28.2%, Unknown: 1.3%.

This pie chart illustrates the distribution of 1,032,136 women receiving an NBCCEDP-funded Pap test from July 2009 to June 2014 by race and ethnicity.

Distribution of Women Receiving Pap Tests by Age

Younger than 30: 4.9%, 30 to 39: 8.0%, 40 to 49: 36.6%, 50 to 64: 49.7%, Other ages: 0.8%.

This pie chart illustrates the distribution of 1,032,136 women receiving an NBCCEDP-funded Pap test from July 2009 to June 2014 by age.

*Slices too small to view were combined into the Other Ages slice (0.8%) and include: 65 and older (0.8%) and Unknown (less than 0.1%). Differences are due to rounding.

Cervical Results and Outcomes
Category Number
Pap tests provided 1,293,033
Pap tests with abnormal results [1] 41,145
Percentage of Pap tests with abnormal results 3.2
Age-adjusted percentage [2] 3.1
Cervical cancers or premalignant cervical lesions [3] 25,466
CIN1 or LSIL 15,750
CIN2 or worse [4] 9,716
Rate of CIN2 or worse detected per 1,000 Pap tests [4] 7.5
Age-adjusted rate per 1,000 Pap tests [2] 7.2

1: Abnormals include Pap test results of: low-grade squamous intraepithelial lesion (LSIL), high-grade squamous intraepithelial lesion (HSIL), atypical squamous cells of undetermined significance - cannot exclude HSIL (ASC-H), atypical glandular cells (AGC), and squamous cell cancer.

2: Adjusted to the age distribution of NBCCEDP participants having Pap tests performed in calendar year 2000.

3: Includes LSIL, HSIL, cervical intraepithelial neoplasia (CIN)1, CIN2, CIN3, carcinoma in situ (CIS), and invasive cervical cancer.

4: Includes HSIL, CIN2, CIN3, CIS, and invasive cervical cancer.

Table includes only NBCCEDP-funded Pap tests. An additional 27,438 women, not included above, were diagnosed with LSIL, HSIL, CIN1, CIN2, CIN3, CIS, or invasive cervical cancer through the NBCCEDP following a Pap test funded through another source.

Breast Cancer Screening

Distribution of Women Receiving Mammograms by Race/Ethnicity

White: 44.8%, Black: 18.2%, Asian/Pacific Islander: 6.4%, American Indian/Alaska Native: 3.5%, Multiracial: 0.5%, Hispanic: 25.1%, Unknown: 1.5%.

This pie chart illustrates the distribution of 1,085,325 women receiving an NBCCEDP-funded mammogram from July 2009 to June 2014 by race and ethnicity.

Distribution of Women Receiving Mammograms by Age

Younger than 40: 1.6%, 40 to 49: 16.1%, 50 to 64: 80.7%, 65 and older: 1.7%.

This pie chart illustrates the distribution of 1,085,325 women receiving an NBCCEDP-funded mammogram from July 2009 to June 2014 by age.

Breast Results and Outcomes
Category Number
Mammograms provided 1,660,940
Mammograms with abnormal results [1] 248,842
Percentage of mammograms with abnormal results 15.0
Age-adjusted percentage [2] 15.7
Breast cancers detected [3] 17,832
Rate of breast cancers detected per 1,000 mammograms 10.7
Age-adjusted rate per 1,000 mammograms [2] 11.0

1: Abnormals include mammogram results of: suspicious abnormality, highly suggestive of malignancy, and assessment incomplete (further imaging studies or film comparisons required).

2: Adjusted to the age distribution of NBCCEDP participants 40 years of age and older having mammograms performed in calendar year 2000.

3: Breast cancers include invasive breast cancer, ductal carcinoma in situ (DCIS), and other in situ excluding lobular carcinoma in situ (LCIS).

Table includes only NBCCEDP-funded mammograms provided to women age 40 and older. An additional 6,254 women, not included above, were diagnosed with CIS (other), DCIS, or invasive breast cancer through the NBCCEDP following a mammogram funded through another source.

Top